ArticleOncotarget2015

MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells.

Cristian Taccioli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.